Pharma Focus Asia

Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

Spinogenix Discovered SPG302, a Novel Therapy for the Treatment of Amyotrophic lateral sclerosis (ALS)

Spinogenix has discovered a novel treatment, SPG302, for Amyotrophic Lateral Sclerosis. SPG302 is a once-daily pill developed as a regenerative therapy for ALS...

UC San Diego Health Introduced Novel Therapy for Melanoma

UC San Diego Health has unveiled a pioneering immunotherapy treatment for metastatic melanoma, heralding a breakthrough in cancer care. This novel approach utilises personalised cellular therapy...

Vera Therapeutics Launches Breakthrough Atacicept Therapy for Immunoglobulin A Nephropathy

Vera Therapeutics has introduced Atacicept, a breakthrough therapy for Immunoglobulin A Nephropathy (IgAN). Atacicept is an investigational recombinant fusion protein that incorporates the soluble...

Biogen Develops QALSODY®, the First Therapy to Treat a Rare, Genetic Form of ALS

Biogen has developed QALSODY®, a groundbreaking therapy for adults with amyotrophic lateral sclerosis linked to a mutation in the superoxide dismutase 1 gene...

Merus Develops Novel Petosemtamab for the Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC)

Merus has introduced a pioneering treatment called petosemtamab, tailored for patients grappling with recurrent or metastatic head and neck squamous cell carcinoma that has advanced despite prior treatment...

Roche Introduced Inavolisib for the Treatment of HER2-negative Breast Cancer

Roche has introduced inavolisib, an oral investigational therapy, combined with palbociclib and fulvestrant, for treating adult patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative...

Amgen Introduces First and Only IMDELLTRA™ T-Cell Engager Therapy for Small Cell Lung Cancer

Amgen has introduced IMDELLTRA™, the first and only T-cell engager therapy for treating extensive-stage small cell lung cancer. IMDELLTRA™ is unique as the only DLL3-targeting bispecific T-cell engager therapy...

Avidity Biosciences Discovers Novel Delpacibart Etedesiran (AOC 1001) for Myotonic Dystrophy Type 1

Avidity Biosciences has pioneered a groundbreaking treatment, del-desiran, for Myotonic Dystrophy Type 1. This investigational therapy targets the root cause...

Pfizer Launches First TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

Pfizer has introduced TIVDAK® to address the needs of patients battling recurrent or metastatic cervical cancer that has progressed despite prior chemotherapy. ...

The University of Texas MD Anderson Cancer Centre Develops Breakthrough PRAME-targeted TCR NK Cell Therapy

The University of Texas MD Anderson Cancer Centre has developed PRAME TCR/IL-15 NK, a revolutionary therapy using engineered T cell receptor natural killer cells to target relapsed/refractory myeloid malignancies....

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024